Literature DB >> 8055373

Bone mineral density in the femur and lumbar vertebrae decreases after twelve weeks of diabetes in spontaneously diabetic-prone BB/Worcester rats.

C E Waud1, S C Marks, R Lew, D T Baran.   

Abstract

The accumulated data indicate that bone mineral density (BMD) is decreased in humans with insulin-dependent diabetes mellitus. The purpose of this study was to prospectively determine sequential lumbar and femoral BMD utilizing dual energy X-ray absorptiometry in rats that spontaneously become diabetic to determine if weight and blood glucose control would prevent the diabetes-related bone mass changes. BMD of the lumbar spine and femur was measured prior to the onset of diabetes and at 3-week intervals after the diagnosis of diabetes for 12 weeks in 14 diabetes-prone BB/Wor rats (DP) and eight diabetes-resistant BB/Wor control rats (DR). At 12 weeks, the lumbar (0.238 +/- 0.013 vs 0.262 +/- 0.007 g/cm2, P < 0.001) and femoral (0.313 +/- 0.013 vs 0.343 +/- 0.013 g/cm2, P < 0.001) BMD were significantly lower in the DP rats despite significantly greater body weights (387 +/- 26 vs 329 +/- 46 g, P < 0.001) and plasma glucose levels of only 178 mg/dl. There was no difference in plasma values of calcium, phosphorus, osteocalcin, or tartrate-resistant acid phosphatase between groups or differences in osteoblast numbers in histologic sections. There was a significant (P < 0.001) decrease in plasma creatinine in the diabetic animals. The results indicate that in this animal model of type I diabetes, spine and femoral BMD do not increase comparable to control despite weight and blood glucose control. This would suggest that the diabetic condition itself affects bone mass in the absence of weight loss and poor blood glucose control.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055373     DOI: 10.1007/bf00301685

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  26 in total

Review 1.  Autoimmune diabetes mellitus in the BB rat.

Authors:  L Crisá; J P Mordes; A A Rossini
Journal:  Diabetes Metab Rev       Date:  1992-04

2.  The bone structure in alloxan-induced diabetes mellitus in rats.

Authors:  C A HERNBERG
Journal:  Acta Med Scand       Date:  1952-03-19

3.  Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.

Authors:  S Hough; L V Avioli; M A Bergfeld; M D Fallon; E Slatopolsky; S L Teitelbaum
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

4.  Decreased cortical thickness & osteopenia in children with diabetes mellitus.

Authors:  J V Santiago; W H McAlister; S K Ratzan; Y Bussman; M W Haymond; G Shackelford; V V Weldon
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

5.  Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis.

Authors:  J Verhaeghe; E van Herck; W J Visser; A M Suiker; M Thomasset; T A Einhorn; E Faierman; R Bouillon
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

6.  Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes.

Authors:  M E Levin; V C Boisseau; L V Avioli
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

7.  Osteopenia in juvenile diabetes.

Authors:  R M Shore; R W Chesney; R B Mazess; P G Rose; G J Bargman
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

8.  Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin.

Authors:  B Ongphiphadhanakul; S Alex; L E Braverman; D T Baran
Journal:  J Bone Miner Res       Date:  1992-10       Impact factor: 6.741

9.  Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat.

Authors:  L E Schneider; H P Schedl; T McCain; M R Haussler
Journal:  Science       Date:  1977-06-24       Impact factor: 47.728

10.  Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment.

Authors:  P K Dixit; R A Ekstrom
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

View more
  10 in total

1.  Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytes.

Authors:  Aimin Wang; Ronald J Midura; Amit Vasanji; Andrew J Wang; Vincent C Hascall
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

2.  Effect of exercise on bone in poorly controlled type 1 diabetes mediated by the ActRIIB/Smad signaling pathway.

Authors:  Jin Yang; Lijun Sun; Xiushan Fan; Bo Yin; Yiting Kang; Liang Tang; Shucheng An
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

3.  Streptozotocin-induced diabetes influences the activity of ecto-nucleoside triphosphate diphosphohydrolase 1 of rat osseous plate membranes.

Authors:  Adriana A Rezende; Sergio O Petenusci; Rosa P M Furriel; Francisco A Leone
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

5.  Evaluation of bone mineral density in children with diabetes mellitus.

Authors:  B Ersoy; D Gökşen; S Darcan; E Mavi; C Oztürk
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

Review 6.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

7.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

8.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

9.  Streptozotocin, type I diabetes severity and bone.

Authors:  Katherine Motyl; Laura R McCabe
Journal:  Biol Proced Online       Date:  2009-03-06       Impact factor: 3.244

10.  Beneficial Effect of Cissus quadrangularis Linn. on Osteopenia Associated with Streptozotocin-Induced Type 1 Diabetes Mellitus in Male Wistar Rats.

Authors:  Srinivasa Rao Sirasanagandla; Sreedhara Ranganath Pai Karkala; Bhagath Kumar Potu; Kumar M R Bhat
Journal:  Adv Pharmacol Sci       Date:  2014-04-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.